Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fidaxomicin versus vancomycin for Clostridioides difficile infection in immunosuppressed adults
2012-000531-88Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2012
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Clostridioides difficile colitis (CDI) comparing Dificlir arm with Vancocin arm (2 arms). Primary endpoint: Sustained clinical cure at Day 26. Started Jul 2012; status: completed.
02
Drugs
fidaxomicinvancomycin
03
Conditions
Clostridioides difficile colitis (CDI)
Beyond the preview
Go deeper on 2012-000531-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000531-88.